Global Hormonal Replacement Therapy (HRT) Drugs Market Report 2020-2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Drugs For Hormonal Replacement Therapy Global Market Report 2020-30: COVID-19 Impact and Recovery” report has been added to ResearchAndMarkets.com’s offering.

The global drugs for hormonal replacement therapy market is expected to decline from $15.6 billion in 2019 to $13.2 billion in 2020 at a compound annual growth rate (CAGR) of -15.8%. The decline is mainly due to the disruption caused by the lockdown measure across various countries to contain COVID-19 spread.

Currently there is less demand for genito-urinary drugs mainly as people are staying at home and are less likely to get exposed to factors that might cause genito-urinary infections, or other hormonal diseases caused by lifestyle changes or eating habits. The market is then expected to recover and grow at a CAGR of 3.5% from 2021 and reach $16.9 billion in 2023.

North America was the largest region in the drugs for hormonal replacement therapy market in 2016. This region is expected to remain the largest during the next five years. The drugs for hormonal replacement therapy market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.

Increasing population of aging and postmenopausal women is driving the drugs for hormonal replacement therapy market growth. Hormonal replacement therapy drugs such as Estrogen, Progestin and others are used to treat medical conditions caused due to menopausal conditions. In 2018, according to a report by The Indian Menopause Society, New Delhi, in India there are 65 million women over the menopausal age affected with menopausal symptoms. According to European Menopause and Andropause Society (EMAS) report, women aged over 60 are expected to reach over 1 billion by 2050.

Furthermore, out of the global women population in 2015, 54% of them were aged over 60 and 62% of them were aged over 80. In 2015, in South Korea, the female population is expected to exceed male population by 2060, out of which 59.6% of female population is expected to suffer from postmenopausal symptoms. Thus, growing women population suffering from menopausal symptoms and aging population drives the market for hormonal replacement therapy drugs market.

Increasing occurrence of side effects due to the intake of drugs for hormonal deficiency may hinder growth of drugs for hormonal replacement therapy market. The side effects include vagina dryness, irregular heartbeat, breast swelling, osteoporosis (weakening of bones) and other effects when women undergo hormonal replacement therapy.

High dosage of drugs for hormonal replacement therapy may cause rapid heartbeat, bloating (a buildup of gas in the stomach and intestines), nausea, indigestion, vaginal bleeding, blood clots, heart attack, breast cancer and others. In 2017, according to an online study, decrease in the intake of drugs for combined hormone therapy showed a decrease in breast cancer cases by 126,000 and cardiovascular disease cases by 76,000. Thus, the increasing side effects of drugs hinders the growth of drugs for hormonal replacement therapy.

Companies in the industry are increasingly developing of drugs for hormonal replacement therapy with better safety profiles and novel drug delivery mechanisms. The drug delivery mechanisms include transdermal estrogen, vaginal estrogen and others. Transdermal estrogen drug delivery is in the form of estradiol transdermal gel, patch, and spray that are used to treat symptoms of menopause, vaginal dryness, itching, burning and others occur due to low estrogen levels. Vaginal estrogen in the form of cream, vaginal ring, vaginal tablets are used to get the hormone estrogen into the system.

Major players in the market are Novartis AG, Bayer AG, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company

Key Topics Covered:

1. Executive Summary

2. Drugs For Hormonal Replacement Therapy Market Characteristics

3. Drugs For Hormonal Replacement Therapy Market Size And Growth

3.1. Global Drugs For Hormonal Replacement Therapy Historic Market, 2015-2019, $ Billion

3.2. Global Drugs For Hormonal Replacement Therapy Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion

4. Drugs For Hormonal Replacement Therapy Market Segmentation

4.1. Global Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

• Estrogen Replacement Therapy
• Human Growth Hormone (HGH) Replacement Therapy
• Thyroid Replacement Therapy
• Testosterone Replacement Therapy

4.2. Global Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

4.3. Global Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

• Hypothyroidism
• Male Hypogonadism
• Growth Hormone Deficiency
• Menopause
• Others

4.4. Global Drugs For Hormonal Replacement Therapy Market, Segmentation By Route of Administration , Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

• Oral
• Parental
• Others

5. Drugs For Hormonal Replacement Therapy Market Regional And Country Analysis

5.1. Global Drugs For Hormonal Replacement Therapy Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

5.2. Global Drugs For Hormonal Replacement Therapy Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Companies Mentioned

• Novartis AG
• Bayer AG
• Pfizer Inc.
• Novo Nordisk A/S
• Eli Lilly and Company
• Abbott
• Mylan Laboratories
• Merck & Co
• Hisamitsu Pharmaceutical Co Inc
• Teva Pharmaceutical Industries Ltd.
• F. Hoffmann-La Roche
• Noven Pharmaceuticals;Inc.
• Orion Pharma AB
• Allergan Plc
• QuatRx Pharmaceuticals
• Wyeth
• Amgen Inc.
• Roche
• Genentech
• TherapeuticsMD

For more information about this report visit https://www.researchandmarkets.com/r/xs8mn1

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900